Investigation of the association between 677C>T and 1298A>C 5,10-methylenetetra-hydrofolate reductase gene polymorphisms and normal-tension glaucoma

Eye

Volumn 23, Issue 1, 2009, Pages 17-24

  Woo, S J ^a   Kim, J Y ^a   Kim, D M ^a   Park, S S ^a   Ko, H S ^a   Yoo, T ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

5,10 methylenetetrahydrofolate reductase gene; Age at diagnosis; Normal tension glaucoma; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GLAUCOMA; HUMAN; HYPERHOMOCYSTEINEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NORMAL TENSION GLAUCOMA; PATHOGENESIS; RESTRICTION MAPPING; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 58249111553     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702920     Document Type: Article

References (44)

1. Quigley HA, Vitale S. Models of open angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci 1997; 38: 83-91.
2. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol 1994; 38: 3-6.
3. Sebag J, Thomas VJ, Epstein DL, Grant WM. Optic disc cupping in arteritic anterior ischemic optic neuropathy resembles glaucomatous cupping. Ophthalmology 1986; 93: 357-361.
4. Hayreh SS. Factors influencing blood flow in the optic nerve head. J Glaucoma 1997; 6: 412-425.
5. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155.
6. Boers GH, Smals AG, Trijbels FJ, Fowler B, Bakkeren JA, Schoonderwaldt HC et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709-815.
7. Genest Jr JJ, McNamara JR, Salem DN, Wilson PW, Schaefer EJ, Malinow MR. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990; 16: 1114-1119.
8. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-881.
9. Mangoni AA, Jackson SHD. Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 2002; 112: 556-565.
10. Frosst P, Blom HJ, Goyette P, Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
11. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994; 7: 195-200.
12. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995; 56: 142-150.
13. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536-545.
14. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y et al. Genetic polymorphism of 5,10-Methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997; 95: 2032-2036.
15. Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41.
16. Yoo JH, Choi GD, Kang SS. Pathogenecity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol 2000; 20: 1921-1925.
17. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-1051.
18. Lee JB, Cho YS, Coe YF, Hong YJ. The prevalence of glaucoma in Korean adults. J Korean Ophthalmol Soc 1993; 34: 65-69.
19. Bonomi L, Marchini G, Marraffa M, Bernardi P, De Franco I, Perfetti S et al. Prevalence of glaucoma and intraocular pressure in a defined population. The Egna-Neumarkt Study. Ophthalmology 1988; 105: 209-215.
20. Airaksinen PJ, Tuulonen A, Werner EB. Clinical evaluation of the optic disc and retinal nerve fiber layer. In: Ritch R, Shields MB, Krupin T (eds.) The Galucomas, 2nd edn. Mosby-Year Book: St Louis, 1996 pp 617-657.
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
22. Cahill M, Karabatzaki M, Donoghue C, Meleady R, Mynett-Johnson LA, Mooney D et al. Thermolabile MTHFR genotype and retinal vascular occlusive disease. Br J Ophthalmol 2001; 85: 88-90.
23. Weger M, Stanger O, Deutschmann H, Leitner FJ, Renner W, Schmut O et al. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutations in patients with retinal artery occlusion. Am J Ophthalmol 2002; 134: 57-61.
24. Abu-Amero KK, Wyngaard CA, Dzimiri N. Prevalence and role of methylenetetrahydrofolate reductase 677 C → T and 1298 A → C polymorphisms in coronary artery disease in Arabs. Arch Pathol Lab Med 2003; 127: 1349-1352.
25. Bleich S, Junemann A, von Ahsen N, Lausen B, Ritter K, Beck G et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm 2002; 109: 1499-1504.
26. Junemann AG, von Ahsen N, Reulbach U, Roedl J, Bonsch D, Kornhuber J et al. C677T variant in the methylentetrahydrofolate reductase gene is a genetic risk factor for primary open-angle glaucoma. Am J Ophthalmol 2005; 139: 721-723.
27. Turacli ME, Tekeli O, Ozdemir F, Akar N. Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation. Clin Exp Ophthalmol 2005; 33: 505-508.
28. Mossbock G, Weger M, Faschinger C, Steinbrugger I, Temmel W, Schmut O et al. Methylenetetrahydrofolatereductase (MTHFR) 677C > T polymorphism and open angle glaucoma. Mol Vis 2006; 12: 356-359.
29. Mabuchi F, Tang S, Kashiwagi K, Yamagata Z, Iijima H, Tsukahara S. Methylenetetrahydrofolate reductase gene polymorphisms c.677C/T and c.1298A/C are not associated with open angle glaucoma. Mol Vis 2006; 12: 735-739.
30. Aung T, Rezaie T, Okada K, Viswanathan AC, Child AH, Brice G et al. Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Invest Ophthalmol Vis Sci 2005; 46: 2816-2822.
31. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M et al. Adult-onset primary open angle glaucoma caused by mutations in optineurin. Science 2002; 295: 1077-1079.
32. Aung T, Ocaka L, Ebenezer ND, Morris AG, Krawczak M, Thiselton DL et al. A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene. Hum Genet 2002; 110: 52-56.
33. Golubnitschafa-Labudova O, Lui R, Decker C, Zhu P, Haefliger IO, Flammer J. Altered gene expression in lymphocytes of patients with normal tension glaucoma. Curr Eye Res 2000; 21: 867-876.
34. Lievers KJ, Boers GH, Verhoef P, den Heijer M, Kluijtmans LA, van der Put NM et al. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med 2001; 79: 522-528.
35. Anello G, Gueant-Rodriguez RM, Bosco P, Gueant JL, Romano A, Namour B et al. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 2004; 15: 859-861.
36. Hayreh SS. Retinal and optic nerve head ischemic disorders and atherosclerosis: role of serotonin. Prog Retin Eye Res 1999; 18: 191-221.
37. O'Brien C. Vasospasm and glaucoma. Br J Ophthalmol 1998; 82: 855-856.
38. Caprioli J, Spaeth GL. Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas. Am J Ophthalmol 1984; 97: 730-737.
39. Airaksinen PJ, Andersen H. Visual field and retinal nerve fiber in early glaucoma after optic disc hemorrhage. Acta Ophthalmol 1983; 61: 186-194.
40. Flammer J, Orgül S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002; 21: 359-393.
41. Cumurcu T, Sahin S, Aydin E. Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma. BMC Ophthalmol 2006; 6: 6.
42. Wang G, Medeiros FA, Barshop BA, Weinreb RN. Total plasma homocysteine and primary open-angle glaucoma. Am J Ophthalmol 2004; 137: 401-406.
43. Kang SS. Treatment of hyperhomocyst(e)inemia: physiological basis. J Nutr 1996; 126(4 Suppl): 1273S-1275S.
44. Girkin CA, DeLeon-Ortega JE, Xie A, McGwin G, Arthur SN, Monheit BE. Comparison of the Moorfields classification using confocal scanning laser ophthalmoscopy and subjective optic disc classification in detecting glaucoma in blacks and whites. Ophthalmology 2006; 113: 2144-2149.